BofA maintains Neutral on PB Fintech, cuts target price to ₹1,410 from ₹1,970.
Policybazaar may gain market share, but health insurance and hospital investments impact valuations.
Livesquawk •
Jefferies maintains Buy rating for PB Fintech, lowers target price to ₹1,540.
Proposed commission cuts may pressure earnings, offset by cost optimization.
Livesquawk •
HSBC downgrades PB Fintech to Hold, slashes target to ₹1,150 citing insurance reforms.
EPS cuts of 56%/17% expected for FY28/29; regulatory clarity is a key catalyst.